Protective effects of dehydrocostus lactone against hydrogen peroxide-induced dysfunction and oxidative stress in osteoblastic MC3T3-E1 cells

Toxicology in Vitro

Volumn 23, Issue 5, 2009, Pages 862-867

  Choi, Eun Mi ^a   Kim, Gun Hee ^a   Lee, Yong Soo ^a  

^a Duksung Women's University   (South Korea)

Author keywords

Dehydrocostus lactone; H2O2; MC3T3 E1 osteoblasts; Oxidative stress; Saussurea lappa Clark

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CARBONYL DERIVATIVE; COLLAGEN; DEHYDROCOSTUS LACTONE; HYDROGEN PEROXIDE; INTERLEUKIN 6; MALONALDEHYDE; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL PROTECTION; CONTROLLED STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OXIDATIVE STRESS;

3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; CALCIUM; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN PEROXIDE; INTERLEUKIN-6; LACTONES; MICE; OSTEOBLASTS; OXIDATIVE STRESS; RANK LIGAND; SESQUITERPENES;

SAUSSUREA LAPPA;

EID: 67649336391     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.05.005     Document Type: Article

References (36)

1. Bai X.C., Lu D., Bai J., Zheng H., Ke Z.Y., and Li X.M. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κB. Biochemical and Biophysical Research Communications 314 (2004) 197-207
2. Berg C., Neumeyer K., and Kirkpatrick P. Teriparatide. Nature Reviews Drug Discovery 2 (2003) 257-258
3. Betteridge D.J. What is oxidative stress?. Metabolism 49 (2000) 3-8
4. Bi Y., Nielsen K.L., Kilts T.M., Yoon A., Karsdal M.A., Wimer H.F., Greenfield E.M., Heegaard A.M., and Young M.F. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone 38 (2005) 778-786
5. Damre A.A., Damre A.S., and Saraf M.N. Evaluation of sesquiterpene lactone fraction of Saussurea lappa on transudative, exudative and proliferative phases of inflammation. Phytotherapy Research 17 (2003) 722-725
6. 2 in primary cultured pig thyrocytes. European Journal of Endocrinology 150 (2004) 841-849
7. Forrest C.M., Mackay G.M., Oxford L., Stoy N., Stone T.W., and Darlington L.G. Kynurenine pathway metabolism in patients with osteoporosis after two years of drug treatment. Clinical and Experimental Pharmacology and Physiology 33 (2005) 1078-1087
8. Fuller K., Kirstein B., and Chambers T.J. Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinology 147 (2006) 1979-1985
9. Garces C., and Garcia L.E. Combination of anabolic and antiresorptive agents for the treatment of osteoporosis. Maturitas 54 (2006) 47-54
10. Garg A.K., and Aggarwal B.B. Reactive oxygen intermediates in TNF signaling. Molecular Immunology 39 (2002) 509-517
11. Helle M., Brakenhoff J.P.J., DeGroot E.R., and Aarden L.A. Interleukin 6 is involved in interleukin 1-induced activities. European Journal of Immunology 18 (1998) 957-959
12. +)-ATPase activity reduction in high glucose-treated human erythrocytes. Free Radical Biology and Medicine 30 (2001) 222-237
13. Jeong S.J., Itokawa T., Shibuya M., Kuwano M., Ono M., Higuchi R., and Miyamoto T. Costunolide, a sesquiterpene lactone from Saussurea lappa, inhibits the VEGFR KDR/Flk-1 signaling pathway. Cancer Letter 187 (2002) 129-133
14. Kotake S., Sato K., Kim K.J., Takahashi N., Udagawa N., Nakamura I., Yamaguchi A., Kishimoto T., Suda T., and Kashiwazaki S. Interleukin-6 and soluble interleukin 6 receptors in the synovial fluids from rheumatoid arthritis patient are responsible for osteoclast-like cell formation. Journal of Bone and Mineral Research 11 (1996) 88-95
15. Lacey D.L., Timms E., and Tan H.L. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
16. Lee H.J., Kim N.Y., Jang M.K., Son H.J., Kim K.M., Sohn D.H., Lee S.H., and Ryu J.H. A sesquiterpene, dehydrocostus lactone, inhibits the expression of inducible nitric oxide synthase and TNF-α in LPS-activated macrophages. Planta Medica 65 (1999) 104-108
17. Lerner U.H. New molecules in the tumor necrosis factor ligand and receptor superfamilies with importance for physiological and pathological bone resorption. CRC Critical Reviews in Oral Biology and Medicine 15 (2004) 64-81
18. Levine R.L., Williams J.A., Stadtman E.R., and Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods in Enzymology 233 (1994) 346-363
19. Maggio D., Barabani M., Pierandrei M., Polidori M.C., Catani M., and Mecocci P. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. The Journal of Clinical Endocrinology and Metabolism 88 (2003) 1523-1527
20. McSheehy P.M., and Chambers T.J. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118 (1986) 824-828
21. Mody N., Parhami F., Sarafian T., and Demer L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radical Biology and Medicine 31 (2001) 509-519
22. Muthusami S., Ramachandran H., Muthusamy B., Vasudevan G., Prabhu V., Subramaniam V., Jagadeesan A., and Narasimhan S. Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats. Clinica Chimica Acta 360 (2005) 81-86
23. Norberg J., and Arnér E.S.J. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biology and Medicine 31 (2001) 1287-1312
24. Quarles L.D., Yohay D.A., Lever L.W., Caton R., and Wenstrup R.J. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. Journal of Bone and Mineral Research 7 (1992) 683-690
25. Rice-Evans, C.A., 1994. Formation of free radicals and mechanisms of action in normal biochemical processes and pathological states. In: C.A. Rice-Evans, R.H. Burdon (Eds.), Free Radical Damage and its Control 28, 131-153.
26. Rodan G.A., and Martin T.J. Therapeutic approaches to bone diseases. Science 289 (2002) 1508-1514
27. Roggia C., Gao Y., Cenci S., Weitzmann M.N., Toraldo G., Isaia G., and Pacifici R. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 13960-13965
28. Rungeler P., Castro V., Mora G., Goren N., Vichnewski W., Pahl H.L., Merfort I., and Schmidt T.J. Inhibition of transcription factor NF-κB by sesquiterpene lactones: a proposed molecular mechanism of action. Bioorganic and Medicinal Chemistry 7 (1999) 2343-2352
29. Shi Q., Lajeunesse D., Reboul P., Martel-Pelletier J., Pelletier J.P., Dehnade F., and Fernandes J.C. Metabolic activity of osteoblasts from periprosthetic trabecular bone in failed total hip arthroplasties and osteoarthritis as markers of osteolysis and loosening. The Journal of Rheumatology 29 (2002) 1437-1445
30. Sitte N., Huber M., Grune T., Ladhoff A.M., Doecke W.D., Zglinicki T., and Davies K.J.A. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging fibroblasts. The FASEB Journal 14 (2001) 1490-1498
31. Sudo H., Kodama H., Amagai Y., Yamamoto S., and Kasai S. In vitro differentiation and calcification in new clonal osteogenic cell line derived from newborn mouse calvariae. The Journal of Cell Biology 96 (1983) 191-198
32. Tuan R.S., Lee F.Y., Konttinen Y.T., Wilkinson J.M., and Smith R.L. What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles?. The Journal of the American Academy of Orthopaedic Surgeons 16 (2008) S42-S48
33. Tullberg-Reinert H., and Jundt G. In situ measurement of collagen synthesis by human bone cells with a Sirius Red-based colorimetric microassay: effects of transforming growth factor β2 and ascorbic acid 2-phosphate. Histochemistry and Cell Biology 112 (1999) 271-276
34. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Progress in Lipid Research 42 (2003) 318-343
35. Vaananen K. Mechanism of osteoclast mediated bone resorption-rationale for the design of new therapeutics. Advanced Drug Delivery Reviews 57 (2005) 959-971
36. Yang S., Madyastha P., Bingel S., Ries W., and Key L. A new superoxide-generating oxidase in murine osteoclasts. The Journal of Biological Chemistry 276 (2001) 5452-5458